Non-Current Liabilities
Amgen·Balance Sheet Statement·9 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Long-term debt | $57.1B | $56.9B | $56.5B | $54.0B | $53.8B | $52.4B | $50.0B | $51.9B |
| Debt Instrument Face Amount | — | — | — | — | — | — | — | $4.0B |
| Liability For Uncertain Tax Positions Noncurrent | $2.2B | $2.3B | $2.3B | $2.4B | $2.5B | $2.6B | $2.7B | $2.8B |
| Other non-current liabilities | $2.4B | $2.2B | $2.3B | $2.2B | $2.3B | $2.2B | $2.4B | $2.4B |
| Debt - Unamortized Discount (Premium) and Issuance Costs, Net | $1.4B | $1.4B | $1.4B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B |
| Total liabilities | $1.1B | $998.0M | $1.1B | $984.0M | $1.1B | $999.0M | $988.0M | $965.0M |
| Hedged Liability - Fair Value Hedge | -$345.0M | -$192.0M | -$343.0M | -$247.0M | -$186.0M | -$159.0M | -$161.0M | -$183.0M |
| Contingent Consideration Liability (Non-Current) | $107.0M | $112.0M | $106.0M | $104.0M | $90.0M | $95.0M | $161.0M | $173.0M |
| Other Debt Including Capitalized Leases | $29.0M | $27.0M | $24.0M | $28.0M | $26.0M | $24.0M | $27.0M | $25.0M |